Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Sold as Clomid, Serophene. Every FDA application for this active ingredient: 2 branded and 7 generic.
As of Nov 15, 2026, FDA lists 9 applications for Clomiphene Citrate (sold as Clomid, Serophene), first approved Feb 1, 1967, with 0 new uses approved and 0 published complete response letters.
First approved: Feb 1, 1967
Applications: 9
New uses approved: 0
Complete response letters: 0
Medicare spending, 2025: $1.2M
Medicare Spending
CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name
Clomid
Part D
$964K
+4%
1,215
Clomiphene Citrate
Part D
$262K
+17495%
708
Milophene
Part D
$4K
New
14
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
CLOMIPHENE CITRATE 50 MG TAB: $4.06 per unitGeneric · -44% in a year
CLOMID 50 MG TABLET: $16.65 per unitBrand · +51% in a year
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA
Sanofi Aventis US
Accord Hlthcare
Novitium Pharma